Utility of adjuvant immunotherapy in high-risk non-metastatic renal cell carcinoma: A real-world experience using national cancer database analysis

被引：0
|
作者：
Garg, H. [1 ]
Bhandari, M. [2 ]
Noel, O. V. [1 ]
Dursun, F. [1 ]
Liss, M. A. [1 ]
Kaushik, D. [1 ]
Ramamurthy, C. [3 ]
Mansour, A. M. [1 ]
机构：
[1] Univ Texas Hlth San Antonio, Dept Urol, San Antonio, TX USA
[2] Univ Texas Hlth San Antonio, Dept Populat Hlth Sci, San Antonio, TX USA
[3] Univ Texas Hlth San Antonio, Dept Med Oncol, San Antonio, TX USA
来源：
EUROPEAN UROLOGY | 2023年 / 83卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0475
引用
收藏
页码：S678 / S679
页数：2
相关论文
共 50 条
  • [1] THE ASSOCIATION OF LYMPH NODE DISSECTION WITH SURVIVAL IN HIGH-RISK NON-METASTATIC RENAL CELL CARCINOMA: AN ANALYSIS OF THE NATIONAL CANCER DATABASE
    Bacic, Janine
    Liu, Tao
    Thompson, R. Houston
    Boorjian, Stephen
    Leibovich, Bradley
    Golijanin, Dragan
    Gershman, Boris
    JOURNAL OF UROLOGY, 2018, 199 (04): : E241 - E242
  • [2] SYSTEMATIC REVIEW AND META-ANALYSIS OF ADJUVANT THERAPY AFTER NEPHRECTOMY FOR HIGH-RISK, NON-METASTATIC RENAL CELL CARCINOMA
    Bandini, Marco
    Capitanio, Umberto
    Smith, Ariane
    Nazani, Sebastiano
    Marchioni, Michele
    Preisser, Felix
    Mazzone, Elio
    Bondarenko, Helen
    Bravi, Carlo
    Tian, Zhe
    Montorsi, Francesco
    Shariat, Shahrokh
    Kapoor, Anil
    Briganti, Alberto
    Karakiewicz, Pierre
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1070 - E1071
  • [3] REAL-WORLD TREATMENT PATTERNS AND TIME TO METASTATIC DISEASE DEVELOPMENT OF PATIENTS WITH HIGH-RISK NON-METASTATIC PROSTATE CANCER
    Tang, Dominic
    Shepherd, David
    Belli, Andrew
    Fung, Vicki
    Hansen, Eric
    Geng, Xiaoqi
    Wang, Ching-Kun
    JOURNAL OF UROLOGY, 2021, 206 : E1069 - E1069
  • [4] Real-world experience of sequential therapies including cytokine/immunotherapy of metastatic renal cell carcinoma in Taiwan
    Hsieh, J. C. -H.
    Chang, W. -C. J.
    ANNALS OF ONCOLOGY, 2015, 26 : 77 - 77
  • [5] Impact of Immunotherapy on Real-World Survival Outcomes in Metastatic Renal Cell Carcinoma
    Poprach, Alexandr
    Kiss, Igor
    Stanik, Michal
    Barusova, Tamara
    Pospisilova, Lenka
    Fiala, Ondrej
    Kopecky, Jindrich
    Richter, Igor
    Melichar, Bohuslav
    Studentova, Hana
    Lakomy, Radek
    Holanek, Milos
    Rozsypalova, Aneta
    Zemankova, Anezka
    Svoboda, Marek
    Buchler, Tomas
    TARGETED ONCOLOGY, 2023, 18 (06) : 893 - 903
  • [6] Impact of Immunotherapy on Real-World Survival Outcomes in Metastatic Renal Cell Carcinoma
    Alexandr Poprach
    Igor Kiss
    Michal Stanik
    Tamara Barusova
    Lenka Pospisilova
    Ondrej Fiala
    Jindrich Kopecky
    Igor Richter
    Bohuslav Melichar
    Hana Studentova
    Radek Lakomy
    Milos Holanek
    Aneta Rozsypalova
    Anezka Zemanková
    Marek Svoboda
    Tomas Buchler
    Targeted Oncology, 2023, 18 : 893 - 903
  • [7] Adjuvant immunotherapy for patients with renal cell carcinoma at increased risk of recurrence following resection: A National Cancer Database analysis.
    Garg, Harshit
    Bhandari, Mukund
    Noel, Onika
    Dursun, Furkan
    Liss, Michael A.
    Kaushik, Dharam
    Pruthi, Deepak K.
    Svatek, Robert S.
    Ramamurthy, Chethan
    Mansour, Ahmed M.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [8] Cabozantinib-Loaded PLGA Nanoparticles: A Potential Adjuvant Strategy for Surgically Resected High-Risk Non-Metastatic Renal Cell Carcinoma
    Lee, Hye Won
    Seo, Hee Seung
    Yeom, Seon-Yong
    Kim, Se-Na
    Kim, Cho Rim
    Park, Dae-Hwan
    Park, Wooram
    Choy, Young Bin
    Park, Chun Gwon
    Seo, Seong Il
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (20)
  • [9] Adjuvant immunotherapy for high-risk renal cell carcinoma-now or never?
    Kulasegaran, Tivya
    Oliveira, Niara
    Gedye, Craig
    Sengupta, Shomik
    BJU INTERNATIONAL, 2025, 135 (02) : 235 - 236
  • [10] Real-world experience with cabozantinib in metastatic clear cell renal cell carcinoma (mccRCC).
    Lemke, Emily
    Shah, Amishi Yogesh
    Chandramohan, Anuradha
    Campbell, Matthew T.
    VanAlstine, Michael
    Jonasch, Eric
    Tannir, Nizar M.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
12345